Literature DB >> 24485270

The use of TriCalcium Phosphate (TCP) and stem cells for the regeneration of osteoperiosteal critical-size mandibular bony defects, an in vitro and preclinical study.

Randa Alfotawei1, Kurt Busuttil Naudi2, David Lappin1, Joseph Barbenel1, Lucy Di Silvio1, Keith Hunter1, Jeremy McMahon1, Ashraf Ayoub1.   

Abstract

The investigation aims to assess the reconstruction of critical-size mandibular bone defects in rabbits using beta-Tricalcium Phosphate (β-TCP) scaffolding loaded with stem cells. A 20 mm-long mandibular osteoperiosteal continuity defect was created in 8 New Zealand rabbits and filled with β-TCP scaffolding. In 6 cases bone marrow stem cells (BMSCs) harvested, and enriched, from the posterior iliac crest of the same rabbit were seeded into the scaffolding, while a scaffold was used alone in two cases chosen at random. Radiographic analysis was carried out immediately following surgery and 4, 8 and 12 weeks postoperatively. Cone Beam CT (CBCT) scanning, biomechanical testing and histology assessments were carried out on the explanted mandibles three months postoperatively. The radiography showed minimal new bone formation in all the cases, with significant amounts of undegraded scaffold material visible. Sporadic areas of bone formation were seen, these did not bridge the gap of the created surgical defect. The mechanical properties of the regenerated bone were of an inferior quality when compared with that of the contralateral non-operated side. The addition of BMSCs to the biodegradable β-TCP scaffold did not improve reconstruction of the created mandibular defect. Despite successful aspiration and culture of BMSCs, the survival of these cells in vivo was questionable.
Copyright © 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Critical-size bone defect; Histomorphometry; Mandible; Rabbit; Stem cells; Tricalcium phosphate scaffolding

Mesh:

Substances:

Year:  2014        PMID: 24485270     DOI: 10.1016/j.jcms.2013.12.006

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  6 in total

1.  A comparison of the in vitro mineralisation and dentinogenic potential of mesenchymal stem cells derived from adipose tissue, bone marrow and dental pulp.

Authors:  O G Davies; P R Cooper; R M Shelton; A J Smith; B A Scheven
Journal:  J Bone Miner Metab       Date:  2014-07-06       Impact factor: 2.626

2.  Assessment of stem cell viability in the initial healing period in rabbits with a cranial bone defect according to the type and form of scaffold.

Authors:  Seung-Hwan Kang; Jun-Beom Park; InSoo Kim; Won Lee; Heesung Kim
Journal:  J Periodontal Implant Sci       Date:  2019-08-09       Impact factor: 2.614

Review 3.  Tissue engineering applications in otolaryngology-The state of translation.

Authors:  Weston L Niermeyer; Cole Rodman; Michael M Li; Tendy Chiang
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-06-19

4.  A novel surgical model for the preclinical assessment of the osseointegration of dental implants: a surgical protocol and pilot study results.

Authors:  Noura M AlOtaibi; Michael Dunne; Ashraf F Ayoub; Kurt B Naudi
Journal:  J Transl Med       Date:  2021-06-28       Impact factor: 5.531

5.  Radiological assessment of bioengineered bone in a muscle flap for the reconstruction of critical-size mandibular defect.

Authors:  Randa Al-Fotawei; Ashraf F Ayoub; Neil Heath; Kurt B Naudi; K Elizabeth Tanner; Matthew J Dalby; Jeremy McMahon
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

6.  Combination of Bioactive Polymeric Membranes and Stem Cells for Periodontal Regeneration: In Vitro and In Vivo Analyses.

Authors:  Flávia Gonçalves; Míriam Santos de Moraes; Lorraine Braga Ferreira; Ana Cláudia Oliveira Carreira; Patrícia Mayumi Kossugue; Letícia Cristina Cidreira Boaro; Ricardo Bentini; Célia Regina da Silva Garcia; Mari Cleide Sogayar; Victor Elias Arana-Chavez; Luiz Henrique Catalani
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.